Can you take Wegovy after a gastric sleeve?

Jump to: Why weight regain happens after a sleeve | How Wegovy works after sleeve surgery | Clinical evidence | Gastric sleeve vs sleeve + Wegovy | Foods to focus on | Physical activity | Mental health after bariatric surgery | Oral vs injectable semaglutide | When to speak to your GP | FAQs | Take home message

You can take Wegovy (semaglutide) after gastric sleeve surgery. There are no contraindications in the prescribing information that prevent its use in people who’ve had bariatric procedures.¹

However, the clinical trials that led to Wegovy’s approval excluded patients who’d had a sleeve gastrectomy. This means using Wegovy after a sleeve falls outside the original STEP trial evidence base.

That said, a growing body of research suggests it can be both safe and effective for managing weight regain after surgery. Studies report around 10-13% total weight loss at 6 to 12 months in post-sleeve patients.²³

Why does weight regain happen after a sleeve?

Gastric sleeve surgery (sleeve gastrectomy) removes roughly 80% of the stomach.

It’s one of the most common bariatric procedures in the UK, working through two main mechanisms: restricting how much food you can eat and changing the gut hormones that regulate appetite.

One of those hormones is GLP-1. After sleeve surgery, our bodies produce significantly more GLP-1, up to 10-fold higher levels than before the operation.⁴

This surge in GLP-1 is thought to be one of the main reasons the surgery works so well for weight loss in the first couple of years.

But this increase in GLP-1 doesn’t last. Research shows that elevated GLP-1 levels following a sleeve gastrectomy tend to decline over 2 to 5 years.⁴ This timeline closely matches when many people start to experience weight regain.

Weight regain after sleeve gastrectomy is more common than many people expect.

Studies report that 20-64% of sleeve patients experience significant weight regain at five or more years after surgery.⁵

How Wegovy works after sleeve surgery

Wegovy is a GLP-1 receptor agonist. It mimics the GLP-1 hormone that our bodies naturally produce in the gut.

It’s injected under the skin once a week, which means it bypasses the digestive system entirely.¹ Because of this, its absorption is unaffected by the reduced stomach size after sleeve surgery.

As the body’s natural GLP-1 production declines in the years after surgery, Wegovy can supplement those fading levels.

It acts on appetite centres in the brain to reduce hunger and cravings, slows gastric emptying to help you feel fuller for longer, and improves insulin sensitivity and blood sugar regulation.

These effects work alongside the physical restriction from the sleeve, maintaining the appetite suppression that made the procedure effective in the first place.

Clinical evidence

While the original STEP trials excluded bariatric surgery patients, several studies have since examined semaglutide specifically in people who’ve had sleeve gastrectomy.

Jamal et al. (2024)

This retrospective study examined 115 patients who experienced weight regain after sleeve gastrectomy.

Those treated with semaglutide achieved an average total weight loss of 10.3% at six months.²

Murvelashvili et al. (2023)

A larger retrospective study of 207 post-bariatric patients compared semaglutide with liraglutide. The semaglutide group achieved 12.9% total weight loss at 12 months, compared with 8.8% for liraglutide.³

Jensen et al. (2023)

This study examined 50 post-bariatric patients treated with GLP-1 receptor agonists. The group achieved a median 8.8% total body weight loss at six months, recovering roughly two-thirds of their post-surgical weight regain.⁵

The BARI-STEP trial

The BARI-STEP trial (NCT05073835) is the first randomised controlled trial to study semaglutide 2.4 mg specifically in post-bariatric patients, including those who’ve had either gastric sleeve or gastric bypass.

Results were presented at EASD 2025. As a randomised controlled trial, it provides more robust evidence than the retrospective studies available so far.

Gastric sleeve alone vs gastric sleeve + Wegovy

Foods to focus on after a gastric sleeve and on Wegovy

Eating with a sleeve requires attention to portion size, food texture, and nutrient density.

As Wegovy reduces the amount of food we eat, it becomes even more important to eat a diet based on nutrient-dense whole foods that minimises ultra-processed foods.

Protein at every meal

Protein is the most critical macronutrient after sleeve gastrectomy. It helps preserve muscle mass during weight loss, supports healing, and promotes lower hunger levels.⁷

Aim for a portion of protein the size of the palm of your hand at every meal, with protein-rich snacks between meals if needed.

Good options include:

• Chicken and turkey, choosing moist, well-cooked preparations
• Fish, including white fish, salmon, mackerel, and tinned sardines
• Eggs (scrambled, poached, or soft-boiled)
• Greek yoghurt and cottage cheese
• Tofu and tempeh
• Lentils and chickpeas (well-cooked and soft)

If you’re struggling to get enough protein, adding protein powders to smoothies, soups, or shakes could be helpful.

Foods that support nutrient levels

Nutritional deficiencies are common after sleeve gastrectomy.

Ten-year follow-up data from the SLEEVEPASS trial found that iron deficiency and vitamin D insufficiency were among the most common nutritional deficiencies in sleeve patients.⁸

Adding Wegovy can further reduce food intake, increasing the risk of deficiency.

Focus on:

• Iron-rich foods: red meat, spinach, lentils, fortified cereals
• Vitamin B12 sources: eggs, dairy, fish, and fortified foods
• Calcium-rich foods: dairy, fortified plant milks, leafy greens, tinned fish with bones
• Vitamin D: oily fish, eggs, and take a supplement in the winter (particularly important in the UK)

Continue any supplements your bariatric team has recommended. BOMSS guidelines advise lifelong nutritional monitoring after sleeve gastrectomy.⁹

Managing dumping syndrome

Dumping syndrome, where food moves too quickly from the stomach into the small intestine, can affect some people after sleeve gastrectomy.¹⁰

Symptoms include nausea, cramping, diarrhoea, dizziness, and sweating after eating.

Semaglutide slows gastric emptying as part of its mechanism of action. This may help reduce dumping symptoms in some people, though this hasn’t been studied directly in post-sleeve patients.

To reduce dumping risk:

• Avoid sugary foods and drinks, particularly on an empty stomach
• Eat your meals slowly and without the distraction of TV or smartphones
• Eat small, frequent meals rather than large portions
• Separate solid food and liquids by at least 30 minutes
• Choose complex carbohydrates (oats, sweet potato, wholegrain bread) over refined options

Foods to limit

• Sugary drinks and fruit juice, as liquid calories bypass restriction and can trigger dumping syndrome
• Ultra-processed foods, which are calorie-dense and nutrient-poor
• Alcohol, as liquid calories don’t trigger fullness and may be absorbed faster after a sleeve
• Carbonated drinks, which can cause discomfort in the smaller stomach

Managing lower hunger levels on Wegovy

• Eat small, frequent meals (five to six per day) rather than trying to eat three large meals
• Prioritise protein and nutrient-dense foods first, as your overall intake will be lower
• Don’t skip meals, even if you don’t feel hungry
• If nausea from Wegovy is a problem, choose soft, easily digestible foods like scrambled eggs, white fish, and mashed vegetables
• Stop eating as soon as you feel full. With Wegovy reducing appetite and the sleeve restricting volume, overeating can cause vomiting.

Physical activity

Regular exercise supports weight loss, helps maintain muscle mass, and improves cardiovascular fitness after bariatric surgery.

A meta-analysis of 22 randomised controlled trials found that post-bariatric patients who exercised regularly lost an additional 1.8 kg and had greater improvements in aerobic fitness and body fat percentage.¹¹

Safe activities after a sleeve

Most forms of exercise are safe once you’ve fully recovered from surgery (typically six to eight weeks). Good options include:

• Walking, even just 10 minutes after dinner, is a good starting point. Research suggests it takes an average of 66 days for a new behaviour to become automatic, and linking a new activity to an existing routine can help it stick.¹⁶ Gradually do a little more as it feels manageable.
• Swimming and water aerobics
• Cycling (stationary or outdoor)
• Low-impact group fitness classes
• Yoga and pilates

Any movement is better than none, and building small, consistent habits matters more than hitting specific targets.

Resistance training

Resistance training is particularly important after sleeve surgery, especially when also taking Wegovy.

Both the surgery and the medication can lead to rapid weight loss, which increases the risk of losing muscle alongside fat.

The same meta-analysis found that exercise improved muscle strength in post-bariatric patients, although it didn’t fully prevent lean mass loss during rapid weight loss.¹¹

Bodyweight exercises like squats, lunges, wall press-ups, and step-ups are effective options that don’t require a gym. Even one session a week is a good starting point, and you can build from there.

Resistance bands and light free weights are also good options. If you’re new to resistance training, consider a session with a personal trainer who has experience working with post-bariatric patients.

Practical tips

• Wait at least six to eight weeks after surgery before starting structured exercise
• Stay hydrated by drinking water before and after exercise, not during meals
• If you experience reflux during exercise, choose upright activities rather than lying-down positions
• Start gradually and build intensity over weeks, particularly if you’ve been inactive
• Carry a small snack in case of low blood sugar during longer exercise sessions

Mental health after bariatric surgery

Mental health is an important but often overlooked aspect of life after bariatric surgery.

Around 19% of people seeking bariatric surgery have clinical depression, and many have anxiety or binge eating disorder before the procedure.¹²

How surgery affects mental health

Bariatric surgery generally improves depressive symptoms in the first two to three years. However, a meta-analysis of over 100,000 patients found that post-operative depression prevalence is still around 15%.¹³

An umbrella review also found a 1.98-fold increased risk of suicide after bariatric surgery compared with the general population or non-surgical controls.¹⁴ This highlights the need for ongoing mental health support after surgery.

Common challenges

• Weight regain after initial success can lead to feelings of failure and shame, particularly if it occurs despite following dietary advice
• Body image concerns may persist even after significant weight loss. Dissatisfaction with excess skin is common and can affect self-confidence
• Transfer addiction, where a previous reliance on food shifts to alcohol, shopping, or other behaviours, affects around 4% of post-bariatric patients¹⁴
• The emotional relationship with food often needs addressing alongside physical changes from surgery and medication

Getting support

• Speak to your GP or bariatric team if you’re experiencing persistent low mood, anxiety, or difficulty coping with weight regain
• Cognitive behavioural therapy (CBT) has evidence for managing both depression and disordered eating after bariatric surgery
• Regular physical activity has consistent evidence for improving mood and reducing symptoms of depression
• Peer support groups for people who’ve had bariatric surgery can help reduce feelings of isolation
• If you notice changes in your relationship with alcohol or other substances after surgery, raise this with your GP
• If you’re starting Wegovy after a period of weight regain, be aware that renewed weight loss can bring up complex emotions about your surgical experience

Oral vs injectable semaglutide after a sleeve

Semaglutide comes in two forms: an injectable version (Wegovy for weight management, Ozempic for type 2 diabetes) and an oral tablet (Rybelsus for type 2 diabetes).

Wegovy is injected under the skin and enters the bloodstream directly. It doesn’t rely on the stomach or gut for absorption, so sleeve surgery has no impact on how it works.¹

Oral semaglutide (Rybelsus) is absorbed through the stomach lining using a special absorption enhancer.

Because sleeve gastrectomy removes roughly 80% of the stomach, absorption could be reduced or unpredictable. There aren’t currently robust studies on the absorption of oral semaglutide after sleeve gastrectomy.

For this reason, the injectable form is the more reliable choice if you’re considering semaglutide after a sleeve.

When to speak to your GP

Contact your GP, prescriber, or bariatric team if you experience any of the following after starting Wegovy:

• Persistent nausea or vomiting that doesn’t improve with smaller meals
• Symptoms of dumping syndrome (dizziness, sweating, cramping after eating) that are new or worsening
• Severe reflux or heartburn
• Abdominal pain that’s persistent or severe
• Rapid weight loss of more than 1 kg per week over several consecutive weeks
• Signs of nutritional deficiency: fatigue, hair loss, brittle nails, numbness or tingling
• Significant mood changes or worsening mental health symptoms

Your bariatric team should be aware that you’re taking Wegovy. They may want to adjust your nutritional monitoring schedule.

Frequently asked questions

Is Wegovy safe after gastric sleeve surgery?

Based on the available evidence, Wegovy appears safe after gastric sleeve surgery. There are no contraindications in the prescribing information specific to bariatric patients.¹

Because Wegovy is injected, it bypasses the altered digestive system entirely. Published studies in post-sleeve patients haven’t reported unique safety concerns.²³

How much weight can I lose with Wegovy after a sleeve?

Research suggests around 10-13% total body weight loss. Jamal et al. reported 10.3% at six months, while Murvelashvili et al. found 12.9% at 12 months.²³

These results are slightly lower than in people who haven’t had surgery but are still clinically meaningful.

Why might I need Wegovy after a gastric sleeve?

The most common reason is weight regain. After sleeve surgery, our bodies experience a surge in GLP-1 that helps suppress appetite.

Over two to five years, these hormone levels tend to decline, which can lead to increased hunger and gradual weight regain.⁴ Wegovy can help by supplementing the fading GLP-1 signal.

Will dumping syndrome get worse on Wegovy?

It’s unlikely. Semaglutide slows gastric emptying, which is the opposite of what happens in dumping syndrome (where food moves too quickly into the small intestine).¹

Some people may find that their dumping symptoms improve, though this hasn’t been studied directly in post-sleeve patients.

Will the GI side effects be worse after a sleeve?

The most common side effects of Wegovy are nausea, vomiting, diarrhoea, and constipation.¹ There’s a theoretical concern these could be more noticeable with a smaller stomach.

However, published studies in post-sleeve patients haven’t reported significantly worse side effects.²³ Starting at a low dose and titrating gradually is important.

What nutritional supplements should I take?

Continue any supplements your bariatric team has recommended. Common post-sleeve supplements include a daily multivitamin, calcium with vitamin D, vitamin B12, and iron.⁹

Can I get Wegovy on the NHS after bariatric surgery?

NICE has approved Wegovy for weight management (TA875), but there’s no specific pathway for prescribing anti-obesity medications after bariatric surgery.⁶

Access will depend on local commissioning decisions and your bariatric team’s assessment. Private prescriptions are another option.

How long after sleeve surgery can I start Wegovy?

There’s no established minimum waiting period. Most clinicians wouldn’t consider Wegovy in the early months when weight loss from the sleeve alone is still ongoing.

It’s typically considered when weight regain becomes apparent, usually two to three years or more after surgery.

Can I take oral semaglutide (Rybelsus) after a sleeve?

This is uncertain. Oral semaglutide is absorbed through the stomach lining, and since sleeve gastrectomy removes around 80% of the stomach, absorption could be reduced or unpredictable.

The injectable form (Wegovy) is the more reliable option because it bypasses the digestive system entirely.

Is there clinical trial evidence for Wegovy after sleeve gastrectomy?

Yes, and it’s growing. Retrospective studies by Jamal et al. and Murvelashvili et al. have shown positive results.²³

The BARI-STEP trial (NCT05073835) is the first randomised controlled trial of semaglutide 2.4 mg specifically in post-bariatric patients, including sleeve, with results presented at EASD 2025.

Take home message

Wegovy can be taken after gastric sleeve surgery, and the growing evidence suggests it’s both safe and effective for managing weight regain.

Because it’s injected rather than swallowed, there are no absorption concerns related to the reduced stomach size.

Weight regain after sleeve surgery is common and is driven by declining gut hormone levels over time.

Wegovy can help by supplementing the body’s fading GLP-1 production, with studies showing 10-13% weight loss at six to twelve months.

Focusing on protein-rich, nutrient-dense foods, regular exercise (particularly resistance training), and ongoing nutritional monitoring will support your weight management alongside medication.

If you’re experiencing weight regain, speak to your bariatric team or GP about whether Wegovy could be appropriate.

Second Nature’s programme combines medication support with personalised nutrition and lifestyle guidance from registered dietitians and nutritionists.

The programme is built around a balanced plate model: half vegetables, quarter protein, quarter complex carbohydrates, plus a serving of healthy fat.

A peer-reviewed study published in JMIR Formative Research found that active subscribers on Second Nature’s semaglutide-supported programme lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss.¹⁵

References

1. Electronic Medicines Compendium. (2026). Wegovy 0.25 mg solution for injection in pre-filled pen: Summary of Product Characteristics.
2. Jamal, M. et al. (2024). Semaglutide vs tirzepatide for weight recurrence after sleeve gastrectomy. Obesity Surgery.
3. Murvelashvili, N. et al. (2023). Effectiveness of semaglutide versus liraglutide for treating post-bariatric surgery patients. Obesity.
4. Hutch, C.R. and Sandoval, D.A. (2017). The role of GLP-1 in the metabolic success of bariatric surgery. Diabetes.
5. Jensen, A.B. et al. (2023). Efficacy of the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide for the treatment of weight regain after bariatric surgery: a retrospective observational study. Obesity Surgery, 33(4), 1017-1025.
6. NICE. (2023). Semaglutide for managing overweight and obesity. Technology Appraisal TA875.
7. Parrott, J. et al. (2017). American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient, 2016 update: micronutrients. Surgery for Obesity and Related Diseases.
8. Saarinen, I. et al. (2025). Nutritional deficiencies after sleeve gastrectomy and Roux-en-Y gastric bypass at 10 years: secondary analysis of the SLEEVEPASS randomized clinical trial. British Journal of Surgery, 112(7), znaf132.
9. O’Kane, M. et al. (2020). British Obesity and Metabolic Surgery Society guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery. Obesity Reviews.
10. Papamargaritis, D. et al. (2012). Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy. Obesity Surgery, 22(10), 1600-1606.
11. Bellicha, A. et al. (2021). Effect of exercise training after bariatric surgery: a meta-analysis of randomised controlled trials. Obesity Reviews.
12. Dawes, A.J. et al. (2016). Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA.
13. Gill, H. et al. (2022). Prevalence and outcomes of depression after bariatric surgery: a systematic review and meta-analysis. Obesity Surgery.
14. Li, S. et al. (2023). Bariatric surgery and mental health outcomes: an umbrella review. Frontiers in Psychiatry.
15. Richards, R. et al. (2025). A remotely delivered, semaglutide-supported weight management program: 12-month outcomes from a retrospective service evaluation. JMIR Formative Research, 9(1), e72577.
16. Lally, P. et al. (2010). How are habits formed: modelling habit formation in the real world. European Journal of Social Psychology, 40(6), 998-1009.